title: Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production.
abstract: Induction of B-cell immunity against infection depends on the initiation of the germinal center (GC) reaction in secondary lymphoid organs. Ex vivo recapitulation of the GC reaction in 2D cultures results in transient cell growth, with poor yield and short-term survival. Furthermore, no reported 2D ex vivo system can modulate the kinetics of a GC-like phenotype or the rate of antibody class switching. This protocol describes a methodology for developing immune organoids that partially mimic the B-cell zone of a lymphoid tissue, for efficient and rapid generation of B cells with a GC-like phenotype from naive murine B cells. The organoid is composed of a bioadhesive protein, gelatin, that is transformed into an ionically cross-linked hydrated network using biocompatible silicate nanoparticles (SiNPs). We explain how to establish the immune organoid culture to sustain immune cell proliferation and transformation into a GC-like phenotype. Starting with cell encapsulation in digested lymphoid tissues, clusters of proliferating B cells with a GC-like phenotype can be generated in the organoids at controlled rates, within ∼1 week. The culture methodology described here is currently the only one that allows the accelerated induction of a GC-like phenotype in B cells and supports a controllable immunoglobulin class-switching reaction. This method can be easily implemented in a typical tissue culture room by personnel with standard mammalian cell culture expertise.
authors.affiliation: Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
authors.forename: Alberto
authors.initials: A
authors.lastname: Purwada
authors.affiliation: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, USA.
authors.forename: Ankur
authors.identifier: http://orcid.org/0000-0003-3357-496X
authors.initials: A
authors.lastname: Singh
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001402:B-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology*; D049109:Cell Proliferation / Q000187:drug effects; D005260:Female; D005780:Gelatin / Q000737:chemistry / Q000494:pharmacology; D018858:Germinal Center / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D053758:Nanoparticles / Q000737:chemistry; D009940:Organoids / Q000166:cytology* / Q000187:drug effects; D010641:Phenotype; D017640:Silicates / Q000737:chemistry; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D017640:Silicates; D005780:Gelatin